Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Acta Physiol Hung ; 95(4): 365-81, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19009912

RESUMO

Physical exercise may improve the metabolic and haemodynamic responses, but the beneficial effects seem to depend on intensity, duration and muscular mass recruitment, which may vary between different types of protocols. This study was performed to evaluate the effects of two distinct moderate/long-term aerobic training protocols in the normal Wistar rat, the treadmill running and the swimming, on several important parameters related to cardiovascular (CV) physiological adaptations, namely: lipid profile, haemorheological measures, lipid peroxidation, peripheral serotonergic system (SS) modulation and sympathetic nervous system (SNS) activation. In both groups under training an HDL-c increment versus the sedentary control was demonstrated. There was a noticeable increase in ADP-induced platelet aggregation in the exercised rats, together with higher PDW and MPV values. The RBC patterns were altered in both groups under training; in the swimming one, however, significantly higher RBC and HCT and lower MCH and MCHC values were found, suggesting renovation of the RBCs. Plasma and platelet SS measures were generally higher in both groups under training, being noticeably relevant the 5-HT and 5-HIAA increment in the treadmill. In opposition, concerning the plasma and platelet NE and E concentrations, the rise was remarkably higher in the rats under a swimming protocol. In conclusion, this study demonstrates that, despite the similar beneficial effects on lipid profile, different aerobic exercise protocols may produce distinct CV physiological adaptations. Therefore, treadmill running was more influent than swimming concerning peripheral SS modulation while swimming was more important on SNS activation, thus recommending a judicious choice of the protocol to be tested in works which make use of rat models of exercise to study physiological or pathophysiological conditions.


Assuntos
Adaptação Fisiológica/fisiologia , Corrida/fisiologia , Serotonina/sangue , Natação/fisiologia , Sistema Nervoso Simpático/fisiologia , Glândulas Suprarrenais/anatomia & histologia , Glândulas Suprarrenais/metabolismo , Animais , Aorta/anatomia & histologia , Aorta/metabolismo , Plaquetas/metabolismo , Sistema Cardiovascular/inervação , Epinefrina/sangue , Epinefrina/metabolismo , Teste de Esforço , Coração/anatomia & histologia , Coração/fisiologia , Hemodinâmica/fisiologia , Ácido Hidroxi-Indolacético/sangue , Ácido Hidroxi-Indolacético/metabolismo , Peroxidação de Lipídeos/fisiologia , Lipídeos/sangue , Masculino , Norepinefrina/sangue , Norepinefrina/metabolismo , Tamanho do Órgão , Condicionamento Físico Animal/fisiologia , Agregação Plaquetária/fisiologia , Ratos , Ratos Wistar , Serotonina/metabolismo
2.
Transplant Proc ; 39(8): 2501-6, 2007 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-17954158

RESUMO

The present study sought to evaluate the prevention and reversion effects of isosorbide-5-mononitrate (Is-5-Mn) on the development of hypertension (HT) and on the underlying vascular and platelet morphofunctional disturbances, using an animal model of cyclosporine (CsA)-induced HT. The following rat groups (n = 8) were tested: (1) a control group (orange juice, for 7 weeks); (2) the CsA group (5 mg/kg/d for 7 weeks); (3) the Is-5-Mn group (150 mg/kg/d, twice a day for 7 weeks); (4) the prevention group (Is-5-Mn + CsA) treated for 2 weeks with Is-5-Mn only and thereafter with both drugs for 7 weeks; (5) the curative group (CsA + Is-5-Mn) beginning 7 weeks after CsA and following thereafter with both drugs for 5 weeks. Blood pressure, lipid profile, vascular lesion, platelet aggregation and morphology, and platelet thromboxane A(2)/vascular prostacyclin equilibrium were evaluated. Is-5-Mn + CsA therapy prevented (systolic blood pressure [SBP]: 114.3 +/- 1.9 mm Hg, P < .001; diastolic blood pressure [DBP]: 97.0 +/- 3.3 mm Hg, P < .001) the CsA-induced HT (SBP: 146.2 +/- 4.5 mm Hg, P < .001; DBP: 124.9 +/- 4.5 mm Hg, P < .001 vs control: SBP: 111.6 +/- 0.7 mm Hg; DBP: 94.6 +/- 1.0 mm Hg), as well as the vascular lesion and the platelet morphofunctional disturbances. The curative group did not show attenuated CsA-induced BP increase; it showed further enhancement of the HT effect (SBP: 159.7 +/- 5.5 mm Hg, P < .05; DBP: 132.8 +/- 2.8 mm Hg), as well as worsened vascular lesions and platelet function, namely a disruption in the TXA(2)/PGI(2) equilibrium. Our data suggested that Is-5-Mn therapy may be a valid choice to prevent the morphofunctional changes associated with CsA-induced HT, when used as a preventive therapy. A careful evaluation of the impact of nitrate therapy should be considered, particularly the negative effect on cardiovascular hemodynamics, when considering its use after previous CsA disturbances have been established.


Assuntos
Plaquetas/fisiologia , Pressão Sanguínea/efeitos dos fármacos , Ciclosporina/efeitos adversos , Hipertensão/induzido quimicamente , Nitratos/uso terapêutico , Agregação Plaquetária/efeitos dos fármacos , Difosfato de Adenosina/farmacologia , Animais , Aorta/patologia , Aorta/ultraestrutura , Plaquetas/efeitos dos fármacos , Epoprostenol/análogos & derivados , Epoprostenol/metabolismo , Hipertensão/tratamento farmacológico , Hipertensão/prevenção & controle , Lipídeos/fisiologia , Masculino , Modelos Animais , Ratos , Ratos Wistar , Tromboxano A2/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA